MENTAL DISORDERS
Clinical trials for MENTAL DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MENTAL DISORDERS trials appear
Sign up with your email to follow new studies for MENTAL DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dosing strategy aims to make Alzheimer's drug safer and more effective
Disease control OngoingThis study tests different dosing schedules of the drug donanemab in about 1,175 people with early symptomatic Alzheimer's disease. The goal is to find a regimen that lowers brain amyloid plaques while reducing the risk of a side effect called ARIA-E (brain swelling or small blee…
Matched conditions: MENTAL DISORDERS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a new drug slow Alzheimer's? large trial underway
Disease control OngoingThis phase 3 study tests whether donanemab, an antibody given through an IV, can safely slow cognitive decline in 1500 people with early Alzheimer's. Participants receive either the drug or a placebo for up to 93 weeks. The main goal is to measure changes in thinking and daily fu…
Matched conditions: MENTAL DISORDERS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New care model aims to speed up mental health help for teens
Disease control OngoingThis study tests a new way of delivering mental health and addiction services to youth aged 14-17. Instead of standard hospital outpatient care, an integrated team offers rapid access to various services like therapy, peer support, and primary care in a youth-friendly setting. Re…
Matched conditions: MENTAL DISORDERS
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Exercise as medicine: new trial tests group workouts for mental health
Disease control OngoingThis study compares a structured group exercise program called Braining with standard advice to exercise on your own. Over 12 weeks, 208 psychiatric patients will attend up to three clinician-led exercise sessions per week. Researchers will measure physical activity, depressive s…
Matched conditions: MENTAL DISORDERS
Phase: NA • Sponsor: Region Stockholm • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a One-Size-Fits-All therapy help depression and anxiety?
Symptom relief TerminatedThis study was designed to test whether a group therapy that uses basic communication skills common to all therapies can help people with depression, anxiety, PTSD, and stress. The therapy avoids specific methods like cognitive-behavioral therapy. The trial was withdrawn before a…
Matched conditions: MENTAL DISORDERS
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Tai chi beats insomnia in breast cancer survivors, study shows
Symptom relief OngoingThis study looks at whether Tai Chi, a gentle moving meditation, can improve chronic insomnia in breast cancer survivors. About 90 women who have completed cancer treatment and have had trouble sleeping for at least 6 months will practice Tai Chi. Researchers will measure sleep q…
Matched conditions: MENTAL DISORDERS
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Can a simple assessment cut sick leave for mental disorders?
Knowledge-focused OngoingThis study tests whether an early assessment of activity limitations by occupational therapists can help people with mental disorders return to work. 150 participants in specialized psychiatric care will either receive the assessment or usual care. The goal is to see if this lead…
Matched conditions: MENTAL DISORDERS
Phase: NA • Sponsor: Göteborg University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
AI alert aims to curb opioid overdoses in real time
Knowledge-focused OngoingThis study tests a machine-learning tool that gives doctors a pop-up alert when they prescribe opioids to a patient at high risk of overdose. The alert explains why the patient is at risk and suggests safer options, like prescribing naloxone or referring to pain therapy. Research…
Matched conditions: MENTAL DISORDERS
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC